FDA.reportPublic FDA data

Device Listing 1539421213

Listing Summary#

Listing key
1539421213
Premarket submission
K180936
Device
ETEST Telavancin (TLA) (0.002-32 ug/mL)
Applicant
Biomerieux S.A.
Product code
JWY
Decision date
2018-07-03